Anzeige
Mehr »
Login
Dienstag, 04.06.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
East Africa Metals: Neues All-Time-High - die 276% Chance jetzt nutzen?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema OVID THERAPEUTICS INC.

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
14.05.Ovid Therapeutics Inc. - S-8, Securities to be offered to employees in employee benefit plans2
14.05.Ovid Therapeutics Inc. - 10-Q, Quarterly Report1
14.05.Ovid Therapeutics Inc. - 8-K, Current Report1
27.03.Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus' Post Grant Review75RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat seizure disorders...
► Artikel lesen
11.03.Ovid Therapeutics Inc reports results for the quarter ended in December - Earnings Summary2
08.03.Ovid Therapeutics Inc. - 10-K, Annual Report1
08.03.Ovid Therapeutics Inc. - 8-K, Current Report1
08.03.Ovid Therapeutics Inc.: Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results115Two pivotal Phase 3 clinical trials studying soticlestat as a treatment for Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) completed enrollment; Takeda anticipates topline data readout by...
► Artikel lesen
06.02.Ovid Therapeutics Inc.: Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference1